• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    4.58 Down 0.16(3.38%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.74
    Open:4.75
    Bid:4.44 x 2000
    Ask:4.88 x 1000
    1y Target Est:8.32
    Beta:3.5
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:4.52 - 4.90
    52wk Range:3.58 - 11.65
    Volume:321,251
    Avg Vol (3m):676,476
    Market Cap:200.21M
    P/E (ttm):N/A
    EPS (ttm):-0.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXDown 3.38%200.21M
    BAXDown 0.52%38.67B
    HSPDown 0.06%15.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):39.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.02
    Quarterly EPS Est (Mar-15) :-0.28
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback